SÉZARY

Clinical trials for SÉZARY explained in plain language.

Never miss a new study

Get alerted when new SÉZARY trials appear

Sign up with your email to follow new studies for SÉZARY, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.

Our safety recommendation!

By submitting, you agree to our Terms of use

Not yet finished but already full! 1

Drug combo shows promise for rare skin cancer

Disease control Ongoing

This study tests whether combining pembrolizumab (an immunotherapy) with gemcitabine (a chemotherapy drug) can help control advanced mycosis fungoides or Sézary syndrome, two rare types of skin lymphoma. It includes 14 adults who have already tried at least one other treatment. T…

Matched conditions: SÉZARY

Phase: PHASE2 • Sponsor: Memorial Sloan Kettering Cancer Center • Aim: Disease control

Last updated May 12, 2026 13:43 UTC

SÉZARY

Get alerted when new SÉZARY trials appear

Drug combo shows promise for rare skin cancer